This company has been marked as potentially delisted and may not be actively trading. NASDAQ:CYAN Cyanotech (CYAN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsEarningsHeadlinesInsider TradesShort InterestTrendsBuy This Stock About Cyanotech Stock (NASDAQ:CYAN) 30 days 90 days 365 days Advanced Chart Get Cyanotech alerts:Sign Up Key Stats Today's Range$0.25▼$0.2750-Day Range$2.83▼$3.2652-Week Range$2.37▼$6.29Volume40,010 shsAverage Volume3,483 shsMarket Capitalization$1.86 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI. Read More Receive CYAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cyanotech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYAN Stock News HeadlinesCyanotech Stock Price History - Investing.comAugust 24, 2025 | investing.comCyanotech Reports Financial Results for the First Quarter of Fiscal 2026August 7, 2025 | finance.yahoo.comNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 trillion calculations per second. Elon Musk and Nvidia’s Jensen Huang are now teaming up to deploy one million of these chips inside what could become the most advanced AI machine on the planet. But according to James Altucher, the real opportunity isn’t in Tesla or Nvidia. He’s uncovered a little-known company that Musk, Nvidia, and even 98% of the Fortune 500 already rely on to make AI 2.0 possible. Nvidia’s CEO has even called this company “essential” to their expansion. | Paradigm Press (Ad)Cyanotech Corp. trims net losses by 40% for fiscal yearJune 20, 2025 | bizjournals.comCyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2025June 20, 2025 | businesswire.comCyanotech Corp (CYAN) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Improved ...February 14, 2025 | finance.yahoo.comQ3 2025 Cyanotech Corp Earnings CallFebruary 13, 2025 | finance.yahoo.comCyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2025February 11, 2025 | finanznachrichten.deSee More Headlines CYAN Stock Analysis - Frequently Asked Questions How were Cyanotech's earnings last quarter? Cyanotech Co. (NASDAQ:CYAN) issued its earnings results on Tuesday, November, 12th. The biotechnology company reported ($0.16) EPS for the quarter. The biotechnology company earned $5.85 million during the quarter. Cyanotech had a negative trailing twelve-month return on equity of 44.71% and a negative net margin of 19.50%. What other stocks do shareholders of Cyanotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cyanotech investors own include AbbVie (ABBV), Gilead Sciences (GILD), Pfizer (PFE), Allena Pharmaceuticals (ALNA), Clarivate (CCC), Karyopharm Therapeutics (KPTI) and Madrigal Pharmaceuticals (MDGL). Company Calendar Last Earnings11/12/2024Today9/10/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolNASDAQ:CYAN CIK768408 Webwww.cyanotech.com Phone(808) 326-1353Fax808-329-4533Employees95Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.66) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$5.27 million Net Margins-19.50% Pretax Margin-19.48% Return on Equity-44.71% Return on Assets-19.12% Debt Debt-to-Equity Ratio0.11 Current Ratio1.06 Quick Ratio0.28 Sales & Book Value Annual Sales$23.07 million Price / Sales0.08 Cash FlowN/A Price / Cash FlowN/A Book Value$1.33 per share Price / Book0.20Miscellaneous Outstanding Shares7,160,000Free Float5,074,000Market Cap$1.86 million OptionableNot Optionable Beta-0.11 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:CYAN) was last updated on 9/10/2025 by MarketBeat.com Staff From Our Partners“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredUnlock Friday's Full Potential: Two Simple Sentences that put profits in investors’ pocketsMost traders stick to the same routine each week. But a little-known market strategy has quietly delivered a 9...Eagle Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredPOP QUIZ: What’s the #1 indicator of a stock’s success? (Nope, not earnings or sales)What indicator do you think is the #1 predictor of stock market success? Most would guess earnings or sales...The Oxford Club | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyanotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyanotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYAN Stock Alerts